Social Media and Pharma Industry, a Paradoxical Oxymoron?
The world’s most highly regulated industry seems doomed to “forward retreat” tiptoeing into Social media. Why? The reason lies on social media’s gist - user generated content (UGC) is the raison d'être but also the main drawback, since the lack of rules on the accuracy of online content (written by the users of websites such as Facebook, Twitter and LinkedIn) makes pharma accountable.
Effective guidance, equally issued by the EU and US drug agencies, is urge...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.